The Federal Trade Commission’s second interim staff report on its ongoing investigation of potential pharmacy benefit manager misdeeds is a parting shot by outgoing FTC chair Lina Khan that also was endorsed by her designated successor, Andrew Ferguson.
Incoming US FTC Chair Endorses Agency Report Challenging PBM Generic Drug Markups
Chairman-designee Andrew Ferguson likely will continue the commission’s investigation of PBMs during the next administration.
